Penobscot Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Buy
5,566
+158
+3% +$18.5K 0.19% 60
2026
Q1
$651K Sell
5,408
-17
-0.3% -$1.96K 0.19% 57
2025
Q4
$571K Buy
5,425
+8
+0.1% +$751 0.18% 59
2025
Q3
$455K Sell
5,417
-41
-0.8% -$3.38K 0.15% 66
2025
Q2
$432K Buy
5,458
+2,251
+70% +$179K 0.15% 63
2025
Q1
$288K Buy
3,207
+380
+13% +$35.5K 0.12% 71
2024
Q4
$281K Buy
2,827
+66
+2% +$6.8K 0.13% 67
2024
Q3
$314K Buy
2,761
+237
+9% +$28.2K 0.17% 59
2024
Q2
$319K Sell
2,524
-19
-0.7% -$2.45K 0.19% 52
2024
Q1
$336K Buy
2,543
+73
+3% +$9K 0.21% 54
2023
Q4
$269K Buy
2,470
+6
+0.2% +$623 0.18% 64
2023
Q3
$254K Buy
+2,464
New +$266K 0.19% 56

Other funds holding MRK

Penobscot Wealth Management's MRK Position: Q2 2026 in Review

Penobscot Wealth Management increased its Merck (MRK) stake by 2.9% in Q2 2026, buying an estimated $18.5K and bringing the position to 5,566 shares worth $715K. The position accounts for 0.19% of the portfolio, ranked #60.

Penobscot Wealth Management first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. 755 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Penobscot Wealth Management held 5,566 shares of Merck worth $715K as of Q2 2026.
  • Penobscot Wealth Management bought 158 Merck shares in Q2 2026, an estimated $18.5K.
  • Merck made up 0.19% of Penobscot Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Penobscot Wealth Management first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • 755 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Penobscot Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.